185 related articles for article (PubMed ID: 3033838)
1. Dissociation of the aggregating effect and the inhibitory effect upon cyclic adenosine monophosphate accumulation by adrenaline and adenosine diphosphate in human platelets.
Stormorken H; Lyberg T; Hakvaag L; Nakstad B
Thromb Res; 1987 Feb; 45(4):363-70. PubMed ID: 3033838
[TBL] [Abstract][Full Text] [Related]
2. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
3. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
4. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets.
Swart SS; Maguire M; Wood JK; Barnett DB
Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911
[TBL] [Abstract][Full Text] [Related]
6. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.
Nurden P; Savi P; Heilmann E; Bihour C; Herbert JM; Maffrand JP; Nurden A
J Clin Invest; 1995 Apr; 95(4):1612-22. PubMed ID: 7706468
[TBL] [Abstract][Full Text] [Related]
7. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
8. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
Steen VM; Holmsen H
Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
Farndale RW; Winkler AB; Martin BR; Barnes MJ
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
[TBL] [Abstract][Full Text] [Related]
11. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
[TBL] [Abstract][Full Text] [Related]
12. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
[TBL] [Abstract][Full Text] [Related]
13. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
14. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
[TBL] [Abstract][Full Text] [Related]
15. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet aggregation by 6-keto-PGE1; lack of an effect on cyclic GMP levels.
Pontecorvo EG; Myers CB; Lippton HL; Kadowitz PJ
Prostaglandins Med; 1981 May; 6(5):473-83. PubMed ID: 6267636
[TBL] [Abstract][Full Text] [Related]
17. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
18. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
Milton JG; Frojmovic MM
J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
20. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
Michel H; Caen JP; Born GV; Miller R; D'Auriac GA; Meyer P
Br J Haematol; 1976 May; 33(1):27-38. PubMed ID: 178342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]